BioCentury | Sep 9, 2020
Finance

Dozens of investors seek liquidity as Grail files for IPO ahead of commercial launches

...Precision oncology play Relay Therapeutics Inc. (NASDAQ:RLAY) raised $460 million, and China-based cancer diagnostics company Burning Rock Biotech Ltd....
BioCentury | Aug 15, 2020
Finance

As CBMG moves to complete go-private deal, pressure on U.S.-listed Chinese companies mounts in Washington

...the first innovative, China-based drug developer to list on NASDAQ in two years. Molecular diagnostics companies Burning Rock Biotech Ltd....
BioCentury | Jun 13, 2020
Finance

With nearly $1B raised overnight, quartet of offerings underscore demand for biotech IPOs

...antibody-oligonucleotide conjugates, added $10.50 (58%) to $28.50 Friday, pushing its market cap above $1 billion. Burning Rock Biotech Ltd....
...and diagnostics, sequencing and supply companies, plus CROs and CMOs. Elizabeth S. Eaton, Staff Writer Avidity Biosciences Inc. Burning Rock Biotech Vaxcyte...
BioCentury | Jun 9, 2020
Finance

Next up on NASDAQ: trio of preclinical companies ready for debuts, plus new filings

...conjugate company Avidity Biosciences LLC set terms for their NASDAQ IPOs Monday. Cancer diagnostic company Burning Rock Biotech Ltd....
...stock exchange and the Shanghai STAR board. Elizabeth S. Eaton, Staff Writer Generation Bio Co. Vaxcyte Inc. Avidity Biosciences LLC Burning Rock Biotech Royalty...
BioCentury | Jun 3, 2020
Finance

Daily Chart: IPO queue grows to 20 life sciences companies

...Co. Ltd. Applied Molecular Transport Inc Progenity Inc. Forma Therapeutics Inc. Repare Therapeutics Inc. Generation Bio Co. Avidity Biosciences LLC Vaxcyte Inc. Royalty Pharma Burning Rock Biotech Arya...
BioCentury | May 25, 2020
Finance

New additions to the IPO queue: Generation Bio, Avidity, Vaxcyte and more

...filing for listings were Royalty Pharma plc, which invests in biopharma royalty streams, and China's Burning Rock Biotech Ltd....
...backed by Perceptive Advisors. Paul Bonanos, Associate Editor Generation Bio Co. Avidity Biosciences LLC SutroVax Inc. Royalty Pharma Burning Rock Biotech Applied Molecular Transport LLC Burning Rock Biotech Ltd. Applied...
BioCentury | Feb 15, 2019
Financial News

China’s Burning Rock, Sciwind close venture rounds

...INDs for two undisclosed compounds in 2019. Shiyu Capital and Kawin participated in the round Hongjiang Li Burning Rock Biotech Hangzhou hepatic Sciwind...
BioCentury | Feb 15, 2019
Financial News

China’s Burning Rock, Sciwind close venture rounds

...and Kawin participated in the round. Burning Rock Biotech, Guangzhou, China Sciwind Biosciences Co. Ltd., Hangzhou, China Hongjiang Li Burning Rock Biotech Hangzhou hepatic Sciwind...
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...tests for cancer risk prediction, early detection, treatment decision guidance and monitoring ~RMB200 ($29) (E) Burning Rock Biotech...
...pharmas has been improved patient recruitment and stratification for Chinese clinical trials. For example, Guangzhou-based Burning Rock Biotech...
...more pharmas seek to capitalize on clinical trial and market opportunities in China, companies like Burning Rock Biotech...
BioCentury | Jun 9, 2017
Finance

Two-way crossing

...million ($80.9 million), is fully invested in 16 Chinese companies. Two are disclosed: bioinformatics play Burning Rock Biotech...
Items per page:
1 - 10 of 14
BioCentury | Sep 9, 2020
Finance

Dozens of investors seek liquidity as Grail files for IPO ahead of commercial launches

...Precision oncology play Relay Therapeutics Inc. (NASDAQ:RLAY) raised $460 million, and China-based cancer diagnostics company Burning Rock Biotech Ltd....
BioCentury | Aug 15, 2020
Finance

As CBMG moves to complete go-private deal, pressure on U.S.-listed Chinese companies mounts in Washington

...the first innovative, China-based drug developer to list on NASDAQ in two years. Molecular diagnostics companies Burning Rock Biotech Ltd....
BioCentury | Jun 13, 2020
Finance

With nearly $1B raised overnight, quartet of offerings underscore demand for biotech IPOs

...antibody-oligonucleotide conjugates, added $10.50 (58%) to $28.50 Friday, pushing its market cap above $1 billion. Burning Rock Biotech Ltd....
...and diagnostics, sequencing and supply companies, plus CROs and CMOs. Elizabeth S. Eaton, Staff Writer Avidity Biosciences Inc. Burning Rock Biotech Vaxcyte...
BioCentury | Jun 9, 2020
Finance

Next up on NASDAQ: trio of preclinical companies ready for debuts, plus new filings

...conjugate company Avidity Biosciences LLC set terms for their NASDAQ IPOs Monday. Cancer diagnostic company Burning Rock Biotech Ltd....
...stock exchange and the Shanghai STAR board. Elizabeth S. Eaton, Staff Writer Generation Bio Co. Vaxcyte Inc. Avidity Biosciences LLC Burning Rock Biotech Royalty...
BioCentury | Jun 3, 2020
Finance

Daily Chart: IPO queue grows to 20 life sciences companies

...Co. Ltd. Applied Molecular Transport Inc Progenity Inc. Forma Therapeutics Inc. Repare Therapeutics Inc. Generation Bio Co. Avidity Biosciences LLC Vaxcyte Inc. Royalty Pharma Burning Rock Biotech Arya...
BioCentury | May 25, 2020
Finance

New additions to the IPO queue: Generation Bio, Avidity, Vaxcyte and more

...filing for listings were Royalty Pharma plc, which invests in biopharma royalty streams, and China's Burning Rock Biotech Ltd....
...backed by Perceptive Advisors. Paul Bonanos, Associate Editor Generation Bio Co. Avidity Biosciences LLC SutroVax Inc. Royalty Pharma Burning Rock Biotech Applied Molecular Transport LLC Burning Rock Biotech Ltd. Applied...
BioCentury | Feb 15, 2019
Financial News

China’s Burning Rock, Sciwind close venture rounds

...INDs for two undisclosed compounds in 2019. Shiyu Capital and Kawin participated in the round Hongjiang Li Burning Rock Biotech Hangzhou hepatic Sciwind...
BioCentury | Feb 15, 2019
Financial News

China’s Burning Rock, Sciwind close venture rounds

...and Kawin participated in the round. Burning Rock Biotech, Guangzhou, China Sciwind Biosciences Co. Ltd., Hangzhou, China Hongjiang Li Burning Rock Biotech Hangzhou hepatic Sciwind...
BioCentury | Sep 21, 2018
Product R&D

China’s rising genomics start-ups

...tests for cancer risk prediction, early detection, treatment decision guidance and monitoring ~RMB200 ($29) (E) Burning Rock Biotech...
...pharmas has been improved patient recruitment and stratification for Chinese clinical trials. For example, Guangzhou-based Burning Rock Biotech...
...more pharmas seek to capitalize on clinical trial and market opportunities in China, companies like Burning Rock Biotech...
BioCentury | Jun 9, 2017
Finance

Two-way crossing

...million ($80.9 million), is fully invested in 16 Chinese companies. Two are disclosed: bioinformatics play Burning Rock Biotech...
Items per page:
1 - 10 of 14